PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807456
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807456
U.S. Electrophysiology Mapping and Ablation Devices Market Size, Share, Trends, Industry Analysis Report By Product (Mapping & Lab Systems, Diagnostic Catheters, Ablation Catheters), By Procedure - Market Forecast, 2025-2034
The U.S. electrophysiology mapping and ablation devices market size is expected to reach USD 22.35 billion by 2034, according to a new study by Polaris Market Research. The report "U.S. Electrophysiology Mapping and Ablation Devices Market Share, Size, Trends, Industry Analysis Report By Product (Mapping & Lab Systems, Diagnostic Catheters, Ablation Catheters), By Procedure; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Electrophysiology mapping and ablation devices are medical tools used to diagnose and treat cardiac arrhythmias. Mapping devices create detailed 3D maps of the heart's electrical activity to locate abnormal signals, while ablation devices use radiofrequency or cryoablation to destroy affected tissue causing the arrhythmia. These minimally invasive procedures are performed via catheters inserted through blood vessels, offering a safer alternative to open-heart surgery. They are commonly used for managing conditions such as atrial fibrillation (AFib), ventricular tachycardia, and supraventricular tachycardia, improving patients' quality of life by restoring normal heart rhythms.
The U.S. electrophysiology mapping and ablation devices market is driven by advanced technologies, high prevalence of arrhythmias, and growing demand for minimally invasive treatments. The U.S. holds a significant share due to robust healthcare infrastructure, increased AFib cases, and strong adoption of innovative devices such as robotic-assisted ablation systems and high-density mapping catheters. Key players, such as Abbott, Medtronic, and Boston Scientific, dominate the market with continuous R&D investments. Regulatory support from the FDA and reimbursement policies further boost market growth. However, high procedure costs and skilled operator requirements remain challenges.
U.S. Electrophysiology Mapping and Ablation Devices Market Report Highlights
In terms of product, the ablation catheters segment dominated the market share in 2024 due to their crucial role in treating a wide range of cardiac arrhythmias, especially atrial fibrillation.
The mapping & lab systems segment is projected to grow at a robust pace in the coming years, owing to their ability to improve the accuracy of ablation procedures and reduce fluoroscopy use.
Based on procedure, the EP ablation procedures segment held the largest market share in 2024 due to the rising incidence of atrial fibrillation and other complex arrhythmias.
The stand-alone EP diagnostic procedures segment is expected to grow at a rapid pace during the forecast period owing to its ability to identify precise arrhythmic foci using high-resolution mapping systems.
A few key market players include Abbott Laboratories; AtriCure, Inc.; Biotronik SE & Co. KG; Boston Scientific Corporation; CardioFocus, Inc.; Freudenberg Medical; GE Healthcare; Johnson & Johnson; Koninklijke Philips N.V.; Medtronic plc; MicroPort Scientific Corporation; and Siemens Healthineers.
Polaris Market Research has segmented the U.S. electrophysiology mapping and ablation devices market report on the basis of product and procedure:
By Product Outlook (Revenue, USD Billion, 2020-2034)
Mapping & Lab Systems
Diagnostic Catheters
Ablation Catheters
Accessory Devices
Transseptal Needles
Navigational Accessories
By Procedure Outlook (Revenue, USD Billion, 2020-2034)
EP Ablation Procedures
Stand-Alone EP Diagnostic Procedures
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. U.S. Electrophysiology Mapping and Ablation Devices Market Insights
- 4.1. Electrophysiology Mapping and Ablation Devices Market - Market Snapshot
- 4.2. Electrophysiology Mapping and Ablation Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Demand for Advanced Rhythm Management Tools in Both Hospital and Ambulatory Settings
- 4.2.1.2. Increasing Burden of Cardiac Conditions
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Risk of Complications During or After the Procedure
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Electrophysiology Mapping and Ablation Devices Market Trends
- 4.6. Value Chain Analysis
5. U.S. Electrophysiology Mapping and Ablation Devices Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Product, 2020-2034 (USD Billion)
- 5.3. Mapping & Lab Systems
- 5.3.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Mapping & Lab Systems, by Region, 2020-2034 (USD Billion)
- 5.4. Diagnostic Catheters
- 5.4.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Diagnostic Catheters, by Region, 2020-2034 (USD Billion)
- 5.5. Ablation Catheters
- 5.5.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Ablation Catheters, by Region, 2020-2034 (USD Billion)
- 5.6. Accessory Devices
- 5.6.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Accessory Devices, by Region, 2020-2034 (USD Billion)
- 5.7. Transseptal Needles
- 5.7.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Transseptal Needles, by Region, 2020-2034 (USD Billion)
- 5.8. Navigational Accessories
- 5.8.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Navigational Accessories, by Region, 2020-2034 (USD Billion)
6. U.S. Electrophysiology Mapping and Ablation Devices Market, by Procedure
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Procedure, 2020-2034 (USD Billion)
- 6.3. EP Ablation Procedures
- 6.3.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by EP Ablation Procedures, by Region, 2020-2034 (USD Billion)
- 6.4. Stand-Alone EP Diagnostic Procedures
- 6.4.1. U.S. Electrophysiology Mapping and Ablation Devices Market, by Stand-Alone EP Diagnostic Procedures, by Region, 2020-2034 (USD Billion)
7. Competitive Landscape
- 7.1. Expansion and Acquisition Analysis
- 7.1.1. Expansion
- 7.1.2. Acquisitions
- 7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
- 8.1. Abbott
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Recent Development
- 8.2. Biotronik SE & Co KG
- 8.2.1. Company Overview
- 8.2.2. Financial Performance
- 8.2.3. Product Benchmarking
- 8.2.4. Recent Development
- 8.3. Boston Scientific Corporation
- 8.3.1. Company Overview
- 8.3.2. Financial Performance
- 8.3.3. Product Benchmarking
- 8.3.4. Recent Development
- 8.4. AtriCure, Inc.
- 8.4.1. Company Overview
- 8.4.2. Financial Performance
- 8.4.3. Product Benchmarking
- 8.4.4. Recent Development
- 8.5. GE HealthCare
- 8.5.1. Company Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Development
- 8.6. Johnson & Johnson
- 8.6.1. Company Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Development
- 8.7. Koninklijke Philips N.V.
- 8.7.1. Company Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Development
- 8.8. Medtronic
- 8.8.1. Company Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Recent Development
- 8.9. MicroPort Scientific Corporation
- 8.9.1. Company Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Recent Development
- 8.10. Siemens Healthineers
- 8.10.1. Company Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Recent Development
- 8.11. CardioFocus, Inc.
- 8.11.1. Company Overview
- 8.11.2. Financial Performance
- 8.11.3. Product Benchmarking
- 8.11.4. Recent Development
- 8.12. Freudenberg Medical
- 8.12.1. Company Overview
- 8.12.2. Financial Performance
- 8.12.3. Product Benchmarking
- 8.12.4. Recent Development
List of Tables:
- Table 1 U.S. Electrophysiology Mapping and Ablation Devices Market, by Product, 2020-2034 (USD Billion)
- Table 2 U.S. Electrophysiology Mapping and Ablation Devices Market, by Procedure, 2020-2034 (USD Billion)
List of Figures:
- Figure 1. U.S. Electrophysiology Mapping and Ablation Devices Market, 2020-2034 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Product
- Figure 7. U.S. Electrophysiology Mapping and Ablation Devices Market, by Product, 2024 & 2034 (USD Billion)
- Figure 8. Market by Procedure
- Figure 9. U.S. Electrophysiology Mapping and Ablation Devices Market, by Procedure, 2024 & 2034 (USD Billion)
